2018
DOI: 10.1136/bmj.j5262
|View full text |Cite|
|
Sign up to set email alerts
|

Real world evidence: experience and lessons from China

Abstract: Xin Sun and colleagues discuss the development of real world evidence in Chinese healthcare and propose strategies to improve its quality and usefulness

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
77
0
5

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 77 publications
(82 citation statements)
references
References 17 publications
0
77
0
5
Order By: Relevance
“…[13][14][15][21][22][23] The large volume of patients in China, together with fast-developing health information systems, furnishes a promising opportunity to enlighten healthcare practice and policy-making based on real-world evidence. [24][25][26][27] Although a growing number of researchers are applying the American-population-based CCI and ECI to a Chinese population, there is no evidence of cross-population generalizability of these comorbidity indices using Chinese administrative data. [28][29][30][31] Therefore, this study aims to evaluate the predictive accuracy of five commonly used indices in in-hospital mortalities of four disease cohorts based on a large administrative database in Shanxi, China.…”
Section: Introductionmentioning
confidence: 99%
“…[13][14][15][21][22][23] The large volume of patients in China, together with fast-developing health information systems, furnishes a promising opportunity to enlighten healthcare practice and policy-making based on real-world evidence. [24][25][26][27] Although a growing number of researchers are applying the American-population-based CCI and ECI to a Chinese population, there is no evidence of cross-population generalizability of these comorbidity indices using Chinese administrative data. [28][29][30][31] Therefore, this study aims to evaluate the predictive accuracy of five commonly used indices in in-hospital mortalities of four disease cohorts based on a large administrative database in Shanxi, China.…”
Section: Introductionmentioning
confidence: 99%
“…Presently, it is difficult to obtain and share real world data between public hospitals in China (30). Research on the life quality of people suffering diseases in China, especially the health utility values of various disease states, are currently an urgent need.…”
Section: Lack Of An Hta Data Support System Entails Strengthening Thementioning
confidence: 99%
“…While randomized controlled trials (RCT) have long been seen as the "gold standard" for evaluating the efficacy of interventions, there are well-known limitations to their generalizability [1]. Accordingly, there have been growing interests in real-world studies (RWS) to generate real-world evidence (RWE) that are more realistic and generalizable [2][3][4][5][6][7][8][9], and RWE is increasingly valued by regulators and payers [10]. In addition, RWE and the RCT can happily co-exist and complement each other [9].…”
Section: Introductionmentioning
confidence: 99%